Medlines
Medlines
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know.  Medicine moves fast... So do we!
Sept. 18, 2026

The Pitt's Big Night and Modernizing Migraine Relief

Key Takeaways

  • New migraine prevention guidelines now position CGRP-targeted therapies as frontline options without requiring patients to fail older drugs first.
  • Patients experiencing four or more headache days per month may qualify for modern CGRP treatments, with treatment response assessed after 8 to 12 weeks.
  • Medical television continues to make waves, highlighted by The Pitt's impressive Emmy run featuring 25 nominations and back-to-back wins, including a major victory for Noah Wyle.
  • Healthcare professionals should stay alert to public health updates, including rising rabies exposures and unusual MRSA outbreaks tied to bouncy castles.

Friday, September 18, 2026

In today's episode, Dr. Alok Patel (@AlokPatelMD) & Eva Johnson cover new migraine prevention guidelines that put CGRP targeted therapies up front as first line options without requiring older drugs first. They explain who qualifies at four or more headache days per month, how to assess response after 8 to 12 weeks, and safety notes for pregnancy. They also break down The Pitt's second Emmy run, with 25 nominations and back to back wins for Noah Wyle and Outstanding Drama. Plus: rising rabies exposures, an MRSA outbreak tied to bouncy castles, and more.


Coverage Timeline:

(00:00) Intro (01:08) New Migraine Guidelines (04:15) The Pitt Sweeps Emmys (08:22) Rabies on the Rise (09:22) MRSA from Bouncy Castles


Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.


Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources


Medlines is a Human Content Production

Frequently Asked Questions

What are the new guidelines for migraine prevention regarding CGRP therapies?

The updated guidelines position CGRP-targeted therapies as frontline options for migraine prevention, meaning patients no longer need to fail older, traditional drugs before qualifying.

Who qualifies for CGRP-targeted migraine prevention therapies under the new guidelines?

Patients who experience four or more headache days per month may qualify for these modern CGRP treatments, with clinical response typically assessed after 8 to 12 weeks.

How did Noah Wyle and the medical drama The Pitt perform at the Emmys?

The Pitt had a massive night at the Emmys with 25 nominations and secured back-to-back wins, including an Outstanding Drama victory and a win for Noah Wyle.

What public health outbreaks were discussed on Medlines?

The hosts covered concerning public health trends, including rising rabies exposures and a surprising MRSA outbreak linked to bouncy castles.